Propane

Propane

SCHEMBL23590

CCC.CNC

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Propane SCHEMBL25366971 1.00
Propane SCHEMBL28102545 0.94 KDM4E (0.40)
Propane SCHEMBL4054745 0.94
Propane SCHEMBL28551707 0.94
Propane SCHEMBL10466038 0.94
Propane SCHEMBL9248047 0.94
Propane SCHEMBL28102546 0.94
Propane SCHEMBL28015864 0.88
Butane SCHEMBL3052765 0.80
Propane SCHEMBL9248656 0.76 TSHR (0.43)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 3077 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4746913-A1 LIPID NANOPARTICLES COMPRISING POLYMER-CONJUGATED LIPIDS AND USES THEREOF Pfizer Inc. (US) 2026-05-27 EP claimed
WO-2026090590-A1 NANOPARTICLE FORMULATIONS FOR THE DELIVERY OF DNA TO ADIPOSE TISSUE Remedium Bio, Inc. (US) 2026-04-30 WO claimed
US-20260108473-A1 BISPECIFIC STEALTH LIPID NANOPARTICLE COMPOSITIONS FOR CELL TARGETING GENERATION BIO CO (US) 2026-04-23 US claimed
US-20260041643-A1 STEALTH LIPID NANOPARTICLE COMPOSITIONS FOR CELL TARGETING GENERATION BIO CO (US) 2026-02-12 US claimed
EP-4687992-A1 LIPID-BASED NANOPARTICLE TARGETED AT ACTIVATED IMMUNE CELLS FOR THE EXPRESSION OF IMMUNE CELL INHIBITING MOLECULE AND USE THEREOF OSE IMMUNOTHERAPEUTICS (FR) 2026-02-11 EP claimed
EP-4687991-A1 LIPID-BASED NANOPARTICLE TARGETED AT ACTIVATED IMMUNE CELLS FOR THE EXPRESSION OF IMMUNE CELL ENHANCING MOLECULE AND USE THEREOF OSE IMMUNOTHERAPEUTICS (FR) 2026-02-11 EP claimed
EP-4687990-A1 METHOD OF SYNTHESIS OF TARGETED LIPID NANOPARTICLE AND USES THEREOF OSE IMMUNOTHERAPEUTICS (FR) 2026-02-11 EP claimed
US-20260021199-A1 RNA LIPID NANOPARTICLES (LNPs) COMPRISING A POLYOXAZOLINE AND/OR POLYOXAZINE POLYMER BioNTech SE (DE) 2026-01-22 US claimed
EP-4661853-A1 LIPID NANOPARTICLES FOR THE TREATMENT OF OCULAR DISEASES Universitat de Barcelona (ES) 2025-12-17 EP claimed
US-20250367320-A1 RNA Particles Comprising Polysarcosine UNIV MAINZ JOHANNES GUTENBERG (DE) 2025-12-04 US claimed
WO-1999025319-A1 PRODUCTION OF MULTIVESICULAR LIPOSOMES DEPOTECH CORPORATION (US) 1999-05-27 WO claimed
WO-1999025385-A1 A METHOD OF INCREASING NUCLEIC ACID SYNTHESIS WITH ULTRASOUND IMARX PHARMACEUTICAL CORP. (US) 1999-05-27 WO claimed
WO-1998042383-A1 CHARGED LIPIDS AND USES FOR THE SAME IMARX PHARMACEUTICAL CORP. (US) 1998-10-01 WO claimed
CN-1188484-A Compounds with growth hormone releasing properties NOVO NORDISK AS (DK) 1998-07-22 CN claimed
EP-0833845-A1 COMPOUNDS WITH GROWTH HORMONE RELEASING PROPERTIES NOVO NORDISK A/S (DK) 1998-04-08 EP claimed
CN-1166136-A Preparation of Multivesicular Liposomes for Controlled Release of Active Agents DEPOTECH CORP (US) 1997-11-26 CN claimed
WO-1997040679-A1 METHODS FOR DELIVERING COMPOUNDS INTO A CELL IMARX PHARMACEUTICAL CORP. (US) 1997-11-06 WO claimed
WO-1997000894-A1 COMPOUNDS WITH GROWTH HORMONE RELEASING PROPERTIES NOVO NORDISK A/S (DK) 1997-01-09 WO claimed
WO-1994011336-A1 IMPROVED PROCESS FOR THE SYNTHESIS OF SUBSTITUTED 1,2,3-AMINODIOLS WARNER-LAMBERT COMPANY (US) 1994-05-26 WO claimed
EP-0452168-A1 Process for the preparation of N-phenyl benzoquinone-imine RHONE-POULENC CHIMIE (FR) 1991-10-16 EP claimed